glenmark_balancesheet_cashflow
TRANSCRIPT
-
8/3/2019 Glenmark_BalanceSheet_Cashflow
1/3
FINANCE - PROFIT AND LOSS - Glenmark Pharmaceuticals Ltd (Curr: Rs in Cr.)
COMPANY/FINANCE/PROFIT AND LOSS/20600/Glenmark Pharma.CmbDetail0CmbCommonsiz
201103 (12) 201003 (12) 200903 (12) 200803 (12)
INCOME :
Sales Turnover 1212.25 1029.69 866.17 1404.82
Excise Duty 10.9 7.59 11.61 33.49
Net Sales 1201.35 1022.1 854.56 1371.33
Other Income 81.14 78.7 139.16 22.56
Stock Adjustments -13.99 2.08 15.16 30.2
Total Income 1268.5 1102.88 1008.88 1424.09
EXPENDITURE :
Raw Materials 325.15 284.43 236.58 433.16
Power & Fuel Cost 10.89 7.72 6.93 18.04
Employee Cost 143.1 111.36 101.34 101.68
Other Manufacturing Expenses 32.21 29.01 29.08 64.58
Selling and Administration Expenses 338.85 277.07 239.27 248.19
Miscellaneous Expenses 60.75 151.35 35.73 54.21
Less: Pre-operative Expenses Capitalised 0 0 0 0
Total Expenditure 910.95 860.94 648.93 919.86
Operating Profit 357.55 241.94 359.95 504.23
Interest 85.75 99.67 94.81 43.64
Gross Profit 271.8 142.27 265.14 460.59
Depreciation 20.99 21.28 19.1 29.44
Profit Before Tax 250.81 120.99 246.04 431.15
Tax 38.8 1.75 83.88 13.45
Fringe Benefit tax 0 0 7.47 8.5
Deferred Tax -0.17 -9.22 -63.24 20.18
Reported Net Profit 212.18 128.46 217.93 389.02
Extraordinary Items -0.03 -0.72 0.36 4.74
Adjusted Net Profit 212.21 129.18 217.57 384.28
Adjst. below Net Profit 0 0 0 0P & L Balance brought forward 851.11 748.1 563.69 234.73
Statutory Appropriations 0 0 0 0
Appropriations 33.88 25.45 33.52 60.06
P & L Balance carried down 1029.41 851.11 748.1 563.69
Dividend 10.81 10.79 10.02 17.15
Preference Dividend 0 0 0 0
Equity Dividend % 40 40 40 70
Earnings Per Share-Unit Curr 7.78 4.69 8.63 15.53
Earnings Per Share(Adj)-Unit Curr 7.78 4.69 8.63 15.53
Book Value-Unit Curr 73.24 65.73 49.1 41.34
Book Value(Adj)-Unit Curr 73.24 65.73 49.1 41.34
-
8/3/2019 Glenmark_BalanceSheet_Cashflow
2/3
0CmbAnnual0
200703 (12) 200603 (12) 200503 (12) 200403 (12) 200303 (12) 200203 (12) 200103 (12) 200003 (12)
837.12 618.44 536.43 380.66 333.64 260.76 190.78 145.34
28.96 55.5 42.69 30.84 32.72 25.08 25.15 11.28
808.16 562.94 493.74 349.82 300.92 235.68 165.63 134.06
22.67 16.94 5.49 2.98 4.28 6.07 3.65 15.45
50.8 -1.33 23.76 21.88 7.79 -6.47 12.96 3.23
881.63 578.55 522.99 374.68 312.99 235.28 182.24 152.74
296.92 194.11 177.07 125.21 101.98 83 70.25 72.17
16.06 9.64 8.37 3.87 1.53 1.13 1.2 0.66
72.75 52.25 40.65 30.25 24.18 18.96 16.44 11.46
37.61 31.93 26.06 16.35 10.88 5.45 6.59 4.9
184.36 148.15 134.67 106.88 95.68 65.24 49.35 24.72
40.32 22.27 17.55 18.66 14.23 11.29 6.37 8.01
0 0 0 0 0 0 0 0
648.02 458.35 404.37 301.22 248.48 185.07 150.2 121.92
233.61 120.2 118.62 73.46 64.51 50.21 32.04 30.82
39.36 17.45 16.73 10.06 10.69 12.91 8.32 1.04
194.25 102.75 101.89 63.4 53.82 37.3 23.72 29.78
23.46 17.48 14.98 10.89 10.33 8.82 5.1 1.11
170.79 85.27 86.91 52.51 43.49 28.48 18.62 28.67
2.64 3.84 14.3 9 5.34 2.26 1.53 6.99
3.97 3.36 0 0 0 0 0 0
29.38 10.77 9.13 1.51 4.96 3.44 0 0
134.8 67.3 63.48 42 33.19 22.78 17.09 21.68
0.79 -0.07 0.03 -0.06 0.12 0 0 0
134.01 67.37 63.45 42.06 33.07 22.78 17.09 21.68
0 0 0 0 0 0 0 -0.01145.64 96.41 49.69 23.59 2.91 0.31 0.67 0.45
0 0 0 0 0 0 0 0
45.71 18.07 16.76 15.9 12.51 20.18 17.45 21.45
234.73 145.64 96.41 49.69 23.59 2.91 0.31 0.67
9.58 8.31 8.3 7.7 6.61 6.06 4.04 5.81
0.69 1.4 0.71 1.05 1.05 1.05 0 0
40 35 35 65 65 60 40 80
11.05 5.43 5.18 6.72 30.77 21.35 16.53 20.85
5.53 2.72 2.59 1.68 1.54 1.07 0.83 1.04
37.5 25.16 22.48 37.98 140.18 116.8 118.36 105.6
18.75 12.58 11.24 9.49 7.01 5.84 5.92 5.28
-
8/3/2019 Glenmark_BalanceSheet_Cashflow
3/3
FINANCE - BALANCE SHEET - Glenmark Pharmaceuticals Ltd (Curr: Rs in Cr.) As on 05/09/2011
COMPANY/FINANCE/BALANCE SHEET/20600/Glenmark Pharma.CmbDetail0CmbCommonsize0
201103 201003 200903 200803 200703 200603 200503 200403 200303 200203 200103 200003
SOURCES OF FUNDS :
Share Capital 27.03 26.98 25.05 24.87 24.01 43.75 43.73 21.85 20.17 20.13 10.09 10.09
Reserves Total 1952.71 1746.43 1204.92 1003.38 426.15 275.01 242.98 213.21 132.39 108.19 109.34 96.46
Equity Share Warrants 0 0 0 0 0 0 0 0 0 0 0 0Equity Application Money 0 0 0 0 0 0 0 0 0 0 0 0
Total Shareholders Funds 1979.74 1773.41 1229.97 1028.25 450.16 318.76 286.71 235.06 152.56 128.32 119.43 106.55
Secured Loans 160.13 48.64 112.21 191.33 170.03 141.83 129.3 102.94 119.36 69.77 52.54 0.12
Unsecured Loans 986.12 711.12 953.7 336.29 738.71 586.84 308.06 11.93 5.39 7.34 19.6 2.18
Total Debt 1146.25 759.76 1065.91 527.62 908.74 728.67 437.36 114.87 124.75 77.11 72.14 2.3
Debt-Equity 0.587 0.43504 0.88463 0.52584 2.13244 2.64961 1.8 0.5388 0.9423 0.7127 0.6598 0.0238
Total Liabilities 3125.99 2533.17 2295.88 1555.87 1358.9 1047.43 724.07 349.93 277.31 205.43 191.57 108.85
APPLICATION OF FUNDS :
Gross Block 362.69 308.63 270.48 483.74 364.65 318.96 258.62 172.35 124.65 141.68 131.54 27.31
Less : Accumulated Depreciation 138.91 118.22 97.67 116.21 87.74 66.4 49.32 34.69 24.33 17.56 8.82 3.8
Less:Impairment of Assets 0 0 0 0 0 0 0 0 0 0 0 0
Net Block 223.78 190.41 172.81 367.53 276.91 252.56 209.3 137.66 100.32 124.12 122.72 23.51
Lease Adjustment 0 0 0 0 0 0 0 0 0 0 0 0
Capital Work in Progress 39.94 46.88 32.45 225.57 156.3 57.56 12.9 24.5 23.24 6.18 0 12.19
Producing Properties 0 0 0 0 0 0 0 0 0 0 0 0
Investments 1041.25 992.92 237.63 196.7 139.1 43.56 26.46 29.94 16.11 2.62 1.73 1.23
Current Assets, Loans & Advances
Inventories 157.01 150.4 130.31 273.63 218.2 138.89 111.06 82.16 44.44 32.23 34.89 15.39
Sundry Debtors 189.34 330.09 409.82 595.16 420.99 282.79 182.1 130.48 123.67 74.21 46.86 27.7
Cash and Bank 30.95 5.08 11.69 11.18 11.39 89.16 109.28 6.77 4.05 4.54 7.17 30.42
Loans and Advances 1691.94 1051.11 1572.68 256.95 398.63 340.26 187.19 39.25 50.27 24.64 11.24 13.39
Total Current Assets 2069.24 1536.68 2124.5 1136.92 1049.21 851.1 589.63 258.66 222.43 135.62 100.16 86.9
Less : Current Liabilities and Provisions
Current Liabilities 205.49 191.04 223.25 269.68 185.2 109.69 68.43 61.71 60.59 42.04 35.03 7.35
Provisions 19.8 19.58 15.95 5.62 1.19 0.81 9.71 12.8 1.17 6.49 4.86 7.63
Total Current Liabilities 225.29 210.62 239.2 275.3 186.39 110.5 78.14 74.51 61.76 48.53 39.89 14.98Net Current Assets 1843.95 1326.06 1885.3 861.62 862.82 740.6 511.49 184.15 160.67 87.09 60.27 71.92
Miscellaneous Expenses not written off 0 0 0 0 0 0 0 0.64 2.41 5.9 6.85 0
Deferred Tax Assets 10.13 9.67 8.81 8.65 3.68 3.14 2.53 2.36 1.54 1.58 0 0
Deferred Tax Liability 33.06 32.77 41.12 104.2 79.91 49.99 38.61 29.32 26.98 22.06 0 0
Net Deferred Tax -22.93 -23.1 -32.31 -95.55 -76.23 -46.85 -36.08 -26.96 -25.44 -20.48 0 0
Current Rato 9.18478 7.29598 8.88169 4.12975 5.62911 7.70226 7.5458 3.4715 3.6015 2.7946 2.5109 5.8011
Quick Assets 1912.23 1386.28 1994.19 863.29 831.01 712.21 478.57 176.5 177.99 103.39 65.27 71.51
Quick Ratio 8.48786 6.5819 8.33691 3.13582 4.45845 6.44534 6.1245 2.3688 2.882 2.1304 1.6362 4.7737
Cash Ratio 0.13738 0.02412 0.04887 0.04061 0.06111 0.80688 1.3985 0.0909 0.0656 0.0936 0.1797 2.0307
Total Assets 3125.99 2533.17 2295.88 1555.87 1358.9 1047.43 724.07 349.93 277.31 205.43 191.57 108.85
Contingent Liabilities 720.93 990.05 1253.19 704.99 43.4 19.59 28.71 25.04 23.15 25.92 21.69 1.9